PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.56%
Revenue growth under 50% of NXPI's 4.02%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.22%
Negative gross profit growth while NXPI is at 4.52%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.70%
Negative EBIT growth while NXPI is at 6.15%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.65%
Negative operating income growth while NXPI is at 6.15%. Joel Greenblatt would press for urgent turnaround measures.
0.17%
Net income growth under 50% of NXPI's 10.15%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.21%
EPS growth under 50% of NXPI's 10.20%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.82%
Diluted EPS growth under 50% of NXPI's 10.28%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.76%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.75%
Reduced diluted shares while NXPI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.09%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
56.45%
OCF growth 1.25-1.5x NXPI's 39.68%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
68.74%
FCF growth 1.25-1.5x NXPI's 55.56%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
91.35%
10Y revenue/share CAGR at 50-75% of NXPI's 177.96%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
37.79%
5Y revenue/share CAGR under 50% of NXPI's 86.38%. Michael Burry would suspect a significant competitive gap or product weakness.
42.33%
3Y revenue/share CAGR at 50-75% of NXPI's 61.90%. Martin Whitman would question if the firm lags behind competitor innovations.
184.81%
10Y OCF/share CAGR under 50% of NXPI's 462.47%. Michael Burry would worry about a persistent underperformance in cash creation.
73.82%
5Y OCF/share CAGR at 50-75% of NXPI's 129.77%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
42.20%
3Y OCF/share CAGR at 50-75% of NXPI's 63.23%. Martin Whitman would suspect weaker recent execution or product competitiveness.
262.30%
Net income/share CAGR at 50-75% of NXPI's 505.80%. Martin Whitman might question if the firm’s product or cost base lags behind.
93.27%
Below 50% of NXPI's 782.47%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
64.93%
Below 50% of NXPI's 620.69%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
57.46%
Below 50% of NXPI's 465.13%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.87%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
65.35%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
570.52%
Dividend/share CAGR of 570.52% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.76%
Dividend/share CAGR of 129.76% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
49.28%
Below 50% of NXPI's 201.27%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-6.85%
Firm’s AR is declining while NXPI shows 1.61%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.32%
Inventory growth well above NXPI's 8.14%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.40%
Asset growth above 1.5x NXPI's 1.78%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.73%
BV/share growth above 1.5x NXPI's 2.36%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
9.57%
Debt growth far above NXPI's 0.02%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.11%
R&D growth drastically higher vs. NXPI's 1.11%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.13%
SG&A declining or stable vs. NXPI's 9.06%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.